000 01572 a2200409 4500
005 20250513123614.0
264 0 _c19970925
008 199709s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.41.8.1725
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrueger, W A
245 0 0 _aInfluence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cAug 1997
300 _a1725-30 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCiprofloxacin
_xadministration & dosage
650 0 4 _aDrug Interactions
650 0 4 _aFeces
_xchemistry
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aIntestinal Mucosa
_xmetabolism
650 0 4 _aIntestines
_xmicrobiology
650 0 4 _aMale
650 0 4 _aProspective Studies
650 0 4 _aSucralfate
_xpharmacokinetics
650 0 4 _aTime Factors
700 1 _aRuckdeschel, G
700 1 _aUnertl, K
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 41
_gno. 8
_gp. 1725-30
856 4 0 _uhttps://doi.org/10.1128/AAC.41.8.1725
_zAvailable from publisher's website
999 _c9237396
_d9237396